Cytosorbents Corporation (CTSO)
undefined
undefined%
At close: undefined
1.01
-4.73%
After-hours Dec 13, 2024, 04:29 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Revenue 36.35M 29.36M 40.11M 39.45M 22.77M 20.25M 13.38M 8.21M 4.06M 3.15M 821.79K 151.57K 36.08K - - - - - 10.00K
Cost of Revenue 13.96M 13.96M 11.05M 11.05M 7.36M 7.49M 5.52M 3.95M 2.21M 2.13M 1.91M 319.30K 11.76K - - - - - 10.00K
Gross Profit 22.39M 15.40M 29.06M 28.40M 15.40M 12.76M 7.86M 4.25M 1.84M 1.01M -1.09M -167.72K 24.32K - - - - - -
Operating Income -31.21M -31.52M -22.75M -10.37M -18.97M -15.58M -9.84M -11.49M -9.30M -7.28M -4.71M -3.49M -4.44M -2.82M -2.43M -3.24M -3.07M -2.96M -80.00K
Interest Income - 133.00K 28.00K 1.20M 1.03M - - - 18.60K - - - - - - - 67.36K - -
Pretax Income -29.32M -33.91M -25.30M -8.96M -20.36M -17.83M -9.14M -12.26M -8.46M -9.71M -5.14M -4.06M -5.48M 2.91M 3.04M -3.27M -3.35M -7.67M -80.00K
Net Income -28.51M -32.81M -24.56M -7.84M -19.27M -17.21M -8.46M -11.94M -8.13M -9.32M -4.68M -3.66M -5.48M -2.91M -2.74M -3.02M -3.35M -7.67M -80.00K
Selling & General & Admin 36.94M 37.14M 38.48M 31.51M 24.47M 22.88M 15.43M 12.28M 8.01M 6.84M 3.49M 1.98M 1.57M 1.07M 1.07M 1.26M 1.65M 1.85M 70.00K
Research & Development 15.73M 15.12M 16.38M 8.81M 12.09M 7.72M 4.05M 4.78M 3.87M 2.43M 1.74M 2.53M 2.89M 1.76M 1.96M 1.98M 1.42M 1.11M -
Other Expenses 936.00K -5.33M -3.06M -1.55M -2.18M -2.25M -1.77M -1.32M -735.86K -2.43M -1.60M -1.19M - - - - - - 10.00K
Operating Expenses 53.60M 46.93M 51.81M 38.77M 34.38M 28.35M 17.71M 15.74M 11.15M 8.29M 3.62M 3.32M 4.46M 2.82M 3.03M 3.24M 3.07M 2.96M 80.00K
Interest Expense 157.89K 132.60K - 1.20M 1.03M 1.46M 749.08K 231.80K 9.30K 310.02K 422.84K 564.43K 1.04M 84.85K 8.14K 22.21K -3.35M 4.74M -
Selling & Marketing Expenses 253.00K 582.00K 615.00K 285.00K 314.00K - - - - - - - - - 307.95K 351.36K - 912.38K -
Cost & Expenses 67.56M 60.88M 62.85M 49.82M 41.74M 35.84M 23.22M 19.70M 13.36M 10.42M 5.54M 3.64M 4.47M 2.82M 3.03M 3.24M 3.07M 2.96M 90.00K
Income Tax -813.74K -1.09M -736.00K -1.13M -1.09M -619.55K -676.74K -318.55K -324.61K -386.00K -458.28K -391.76K 1.04M 5.82M 298.79K -248.53K 3.35M 7.67M -
Shares Outstanding (Basic) 44.66M 43.57M 43.36M 38.82M 32.26M 30.72M 27.61M 25.43M 24.89M 14.38M 9.44M 7.93M 6.41M 3.92M 1.66M 1.00M 993.94K 598.24K 310.00K
Shares Outstanding (Diluted) 44.66M 43.57M 43.36M 38.82M 32.26M 30.72M 27.61M 25.43M 24.89M 14.38M 9.44M 7.93M 6.41M 3.92M 1.66M 1.00M 993.94K 598.24K 310.00K
EPS (Basic) -0.64 -0.75 -0.57 -0.2 -0.6 -0.56 -0.31 -0.47 -0.33 -0.65 -0.5 -0.46 -0.86 -0.74 -1.64 -3 -3.37 -12.82 -0.26
EPS (Diluted) -0.64 -0.75 -0.57 -0.2 -0.6 -0.56 -0.31 -0.47 -0.33 -0.65 -0.5 -0.46 -0.86 -0.74 -1.64 -3 -3.37 -12.82 -0.26
EBITDA -28.81M -30.00M -22.01M -9.71M -18.74M -15.98M -8.17M -11.86M -9.19M -6.83M -4.65M -3.44M -4.40M -2.81M -2.98M -3.14M -3.16M -1.74M -70.00K
Depreciation & Amortization 2.03M 1.13M 1.13M 660.79K 581.53K 390.55K 218.27K 161.61K 112.97K 65.55K 64.35K 54.61K 39.15K 17.80K 51.70K 103.70K 190.44K 1.26M 10.00K